نتائج البحث

Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials.

• Authors : Krishnan A; Aviceda Therapeutics, Cambridge, MA 02142, USA.; Callanan DG

• Source: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2024 Apr 09; Vol. 17 (4). Date of Electronic Publication: 2024 Apr 09.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print)

تفاصيل العنوان

Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance.

• Authors : Greene MK; The Patrick G Johnston Centre for Cancer Research, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7AE, UK.; Johnston MC

• Source: Cancers [Cancers (Basel)] 2021 Dec 07; Vol. 13 (24). Date of Electronic Publication: 2021 Dec 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print)

تفاصيل العنوان

A novel RCE1 isoform is required for H-Ras plasma membrane localization and is regulated by USP17.

• Authors : Jaworski J; School of Pharmacy, Queen's University Belfast, McClay Research Building, 97 Lisburn Road, Belfast BT9 7BL, U.K.; Govender U

Subjects: Cell Membrane/Cell Membrane/Cell Membrane/*metabolism ; Endopeptidases/Endopeptidases/Endopeptidases/*metabolism ; Endopeptidases/Endopeptidases/Endopeptidases/*physiology

• Source: The Biochemical journal [Biochem J] 2014 Jan 15; Vol. 457 (2), pp. 289-300.Publisher: Published by Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 2984726R Publication Model: Print Cited

تفاصيل العنوان